Clinical Trial Update: Safety and Efficacy Study in Patients With Local Advanced Larynx/Hypolarynx Carcinoma Treated With TPF Induction Chemotherapy Followed by Hyperfractionated Radiotherapy With Cetuximab [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy study of TPF induction chemotherapy followed by hyperfractionated radiotherapy with cetuximab in locally advanced larynx/hypolaryn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngeal Neoplasms

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Fundacion Miguel Servet | Conditions: Laryngeal Neoplasms | Phase 2 | Status: TERMINATED